Advertisement

Journal of Cancer Survivorship

, Volume 13, Issue 1, pp 66–74 | Cite as

Smoking cessation attitudes and practices among cancer survivors – United States, 2015

  • M. Shayne GallawayEmail author
  • Rebecca Glover-Kudon
  • Behnoosh Momin
  • Mary Puckett
  • Natasha Buchanan Lunsford
  • Kathleen R. Ragan
  • Elizabeth A. Rohan
  • Stephen Babb
Article

Abstract

Purpose

The prevalence of smoking among cancer survivors is similar to the general population. However, there is little evidence on the prevalence of specific smoking cessation behaviors among adult cancer survivors.

Methods

The 2015 National Health Interview Survey (NHIS) data were analyzed to examine the prevalence of smoking cessation behaviors and use of treatments among cancer survivors. Weighted self-reported prevalence estimates and 95% confidence intervals were calculated using a sample of 2527 cancer survivors.

Results

Among this sample of US cancer survivors, 12% were current smokers, 37% were former smokers, and 51% were never smokers. Compared with former and never smokers, current smokers were younger (< 65 years), less educated, and less likely to report being insured or Medicaid health insurance (p < 0.01). More males were former smokers than current or never smokers. Current smokers reported wanting to quit (57%), a past year quit attempt (49%), or a health professional advised them to quit (66%). Current smokers reported the use of smoking cessation counseling (8%) or medication (38%).

Conclusions

Even after a cancer diagnosis, about one in eight cancer survivors continued to smoke. All could have received advice to quit smoking by a health professional, but a third did not.

Implications for Cancer Survivors

Health professionals could consistently advise cancer survivors about the increased risks associated with continued smoking, provide them with cessation counseling and medications, refer them to other free cessation resources, and inform them of cessation treatments covered by their health insurance.

Keywords

Smoking Smoking cessation Cancer survivor Medication National survey 

Notes

Author contributions

Gallaway: conceptualization, methodology, formal analysis, investigation, writing original-draft, writing-review and editing, and project administration. Glover-Kudon: conceptualization, methodology, writing original-draft, writing-review and editing, resources, and project administration. Momin, Puckett, Buchanan Lunsford, Ragan, and Rohan: conceptualization, methodology, writing original-draft, writing-review, and editing. Babb: conceptualization, methodology, writing original-draft, writing-review and editing, resources, and project administration.

Funding

All funding was provided by the Centers for Disease Control and Prevention.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not include any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    U.S. Department of Health and Human Services. The health consequences of smoking: 50 years of progress: a report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.Google Scholar
  2. 2.
    Henley SJ, Thomas C, Sharapova S, Momin B, Massetti G, Winn D, et al. Vital signs: disparities in tobacco-related cancer incidence and mortality—United States, 2004–2013. MMWR Morb Mortal Wkly Rep. 2016;65(44):1212–8.Google Scholar
  3. 3.
    US Cancer Statistics Working Group. United States cancer statistics: 1999–2013 incidence and mortality web-based report. Atlanta: U.S. Department of Health and Human Services, CDC, National Cancer Institute; 2016.Google Scholar
  4. 4.
    Emmons K, Li F, Whitton J, Mertens A, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol. 2002;20(6):1608–16.Google Scholar
  5. 5.
    Cox L, Africano N, Tercyak K, Taylor K. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98(3):632–44.Google Scholar
  6. 6.
    Tyc VL. A comparison of tobacco-related risk factors between adolescents with and without cancer. J Pediatr Psychol. 2005;30(4):359–70.Google Scholar
  7. 7.
    Underwood JM, Townsend J, Tai E, White A, Davis S, Fairley T. Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis. J Cancer Surviv. 2012;6(3):333–44.Google Scholar
  8. 8.
    Shoemaker M, White M, Hawkins N, Hayes N. Prevalence of smoking and obesity among U.S. cancer survivors: estimates from the National Health Interview Survey, 2008–2012. Oncol Nurs Forum. 2016;43(4):436–41.Google Scholar
  9. 9.
    Ramaswamy AT, Toll B, Chagpar A, Judson B. Smoking, cessation, and cessation counseling in patients with cancer: a population-based analysis. Cancer. 2016;122(8):1247–53.Google Scholar
  10. 10.
    Mayer DK, Carlson J. Smoking patterns in cancer survivors. Nicotine Tob Res. 2011;13(1):34–40.  https://doi.org/10.1093/ntr/ntq199.Google Scholar
  11. 11.
    Park B, Kong SY, Kim J, Kim Y, Park IH, Jung SY, et al. Health behaviors of cancer survivors in nationwide cross-sectional survey in Korea: higher alcohol drinking, lower smoking, and physical inactivity pattern in survivors with higher household income. Medicine (Baltimore). 2015;94(31):e1214.  https://doi.org/10.1097/MD.0000000000001214.Google Scholar
  12. 12.
    Tseng TS, Lin HY, Martin MY, Chen T, Partridge EE. Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey. J Cancer Surviv. 2010;4(4):313–21.  https://doi.org/10.1007/s11764-010-0127-9.Google Scholar
  13. 13.
    Tseng TS, Lin HY, Moody-Thomas S, Martin M, Chen T. Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999-2008. BMC Public Health. 2012;12:784.  https://doi.org/10.1186/1471-2458-12-784.Google Scholar
  14. 14.
    Westmaas JL, Alcaraz KI, Berg CJ, Stein KD. Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: findings from a nationwide survey nine years after diagnosis. Cancer Epidemiol Biomark Prev. 2014;23(9):1783–92.  https://doi.org/10.1158/1055-9965.EPI-14-0046.Google Scholar
  15. 15.
    Wang Z, McLoone P, Morrison DS. Diet, exercise, obesity, smoking and alcohol consumption in cancer survivors and the general population: a comparative study of 16 282 individuals. Br J Cancer. 2015;112(3):572–5.  https://doi.org/10.1038/bjc.2014.598.Google Scholar
  16. 16.
    Division of Cancer Prevention and Control Centers for Disease Control and Prevention. National Comprehensive Cancer Control Program (NCCCP). 2017. https://www.cdc.gov/cancer/ncccp/. Accessed 3 April 2017.
  17. 17.
    Klosky JL, Tyc V, Garces Webb D, Buscemi J, Klesges R, Hudson M. Emerging issues in smoking among adolescent and adult cancer survivors. Cancer. 2007;110(11):2408–19.Google Scholar
  18. 18.
    Mackenbach JP. Determinants of levels and changes of physical functioning in chronically ill persons: results from the GLOBE Study. J Epidemiol Community Health. 2001;55(9):631–8.Google Scholar
  19. 19.
    Mariotto A. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomark Prev. 2007;16(3):566–71.Google Scholar
  20. 20.
    Richardson GE. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993;119(5):383–90.Google Scholar
  21. 21.
    Des Rochers C, Dische S, Saunders MI. The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clin Oncol. 1992;4(4):214–6.Google Scholar
  22. 22.
    Gritz E. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomark Prev. 2005;14(10):2287–93.Google Scholar
  23. 23.
    Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159–63.  https://doi.org/10.1056/NEJM199301213280302.Google Scholar
  24. 24.
    Blum A. Cancer prevention: preventing tobacco-related cancers. In: Devita VTHS, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven Publishers; 1997. p. 545–57.Google Scholar
  25. 25.
    Day GL. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994;86(2):131–7.Google Scholar
  26. 26.
    Do KA, Johnson M, Doherty D, Lee JJ, Wu X, Dong Q, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003;14(2):131–8.Google Scholar
  27. 27.
    Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006;98(7):441–50.Google Scholar
  28. 28.
    Wynder E. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer. 1977;40(S4):1872–8.Google Scholar
  29. 29.
    Shiels MS, Gibson T, Sampson J, Alabanes D, Andreotti G, Freeman LB, et al. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol. 2014;32(35):3989–95.  https://doi.org/10.1200/JCO.2014.56.8220.Google Scholar
  30. 30.
    Gan SJ, Dahlstrom K, Peck B, Caywood W, Li G, Wei Q, et al. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer. 2013;119(14):2593–601.Google Scholar
  31. 31.
    Al-Mamgani A, van Rooij PH, Mehilal R, Verduijn GM, Tans L, Kwa SL. Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy. Eur Arch Otorhinolaryngol. 2014;271(1):125–32.  https://doi.org/10.1007/s00405-013-2608-8.Google Scholar
  32. 32.
    Browman GP, Mohide EA, Willan A, Hodson I, Wong G, Grimard L, et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck. 2002;24(12):1031–7.  https://doi.org/10.1002/hed.10168.Google Scholar
  33. 33.
    Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74(11):878–84.  https://doi.org/10.1212/WNL.0b013e3181d55f38.Google Scholar
  34. 34.
    Choi SH, Terrell JE, Bradford CR, Ghanem T, Spector ME, Wolf GT, et al. Does quitting smoking make a difference among newly diagnosed head and neck cancer patients? Nicotine Tob Res. 2016;18(12):2216–24.  https://doi.org/10.1093/ntr/ntw189.Google Scholar
  35. 35.
    Dobson Amato KA, Hyland A, Reed R, Mahoney MC, Marshall J, Giovino G, et al. Tobacco cessation may improve lung cancer patient survival. J Thorac Oncol. 2015;10(7):1014–9.  https://doi.org/10.1097/JTO.0000000000000578.Google Scholar
  36. 36.
    Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, et al. Cigarette smoking before and after breast cancer diagnosis: mortality from breast cancer and smoking-related diseases. J Clin Oncol. 2016;34(12):1315–22.  https://doi.org/10.1200/JCO.2015.63.9328.Google Scholar
  37. 37.
    Roach MC, Rehman S, DeWees TA, Abraham CD, Bradley JD, Robinson CG. It’s never too late: smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival. Pract Radiat Oncol. 2016;6(1):12–8.  https://doi.org/10.1016/j.prro.2015.09.005.Google Scholar
  38. 38.
    Sandoval M, Font R, Manos M, Dicenta M, Quintana MJ, Bosch FX, et al. The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain. Int J Oral Maxillofac Surg. 2009;38(1):31–9.  https://doi.org/10.1016/j.ijom.2008.09.004.Google Scholar
  39. 39.
    Sardari Nia P, Weyler J, Colpaert C, Vermeulen P, Van Marck E, Van Schil P. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer. 2005;47(3):351–9.  https://doi.org/10.1016/j.lungcan.2004.08.011.Google Scholar
  40. 40.
    Tao L, Wang R, Gao YT, Yuan JM. Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai cohort study. Cancer Epidemiol Biomark Prev. 2013;22(12):2404–11.  https://doi.org/10.1158/1055-9965.EPI-13-0805-T.Google Scholar
  41. 41.
    Siu AL. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(8):622–34.Google Scholar
  42. 42.
    Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville: US Department of Health and Human Services, Public Health Service; 2008.Google Scholar
  43. 43.
    Cahill K, Stead L, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, the Cochrane Library. 1996(1).Google Scholar
  44. 44.
    Lancaster T, Stead L. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev Cochrane Lib. 1996;(2).Google Scholar
  45. 45.
    Silagy C. Nicotine replacement therapies in smoking cessation. Biomed Pharmacother. 1994;48(8–9):407–8.Google Scholar
  46. 46.
    Babb S. Quitting smoking among adults—United States, 2000–2015. Morb Mortal Wkly Rep. 2017;65(52):1457–64.Google Scholar
  47. 47.
    Gritz ER, Fingeret M, Vidrine D, Lazev A, Mehta N, Reece G. Successes and failures of the teachable moment. Cancer. 2006;106(1):17–27.Google Scholar
  48. 48.
    National Center for Health Statistics. National Health Interview Survey 2015. National Center for Health Statistics. http://www.cdc.gov/nchs/nhis/quest_data_related_1997_forward.htm.2016. Accessed 1 March 2017.
  49. 49.
    Centers for Disease Control and Prevention. Current cigarette smoking among adults in the United States. Atlanta, Georgia; 2016. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm. Accessed 17 Oct 2017.
  50. 50.
    Berg CJ, Thomas A, Mertens A, Schauer G, Pinsker E, Ahluwalia J, et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psycho-Oncology. 2013;22(4):799–806.Google Scholar
  51. 51.
    Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99(21):1634–43.Google Scholar
  52. 52.
    Coups E, Ostroff J. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005;40(6):702–11.Google Scholar
  53. 53.
    Shields PG. Smoking cessation, version 1.2016 clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14(11):1430–68.Google Scholar
  54. 54.
    Japuntich S, Luberto C, Streck J, Rigotti N, Temel J, Lanuti M, et al. Integrating tobacco treatment into thoracic oncology settings: lessons learned. J Health Psychol. 2016;21(12):2813–23.Google Scholar
  55. 55.
    Lucchiari C, Masiero M, Botturi A, Pravettoni G. Helping patients to reduce tobacco consumption in oncology: a narrative review. Springerplus. 2016;5(1):1–18.Google Scholar
  56. 56.
    Pommeranke A, Alberg A, Brandon T, Croghan I, Cummings KM, Dresler C, et al. Physician preferences in tobacco cessation support for cancer patients: a survey of National Cancer Institute Designated Cancer Centers. San Diego: American Association for Cancer Research; 2014.Google Scholar
  57. 57.
    Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hutson A, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. 2013;8(5):543–8.  https://doi.org/10.1097/JTO.0b013e318288dc96.Google Scholar
  58. 58.
    Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, Hutson A, et al. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013;9(5):258–62.  https://doi.org/10.1200/JOP.2013.001025.Google Scholar
  59. 59.
    Sabatino S. Provider counseling about health behaviors among cancer survivors in the United States. J Clin Oncol. 2007;25(15):2100–6.Google Scholar
  60. 60.
    Weaver KE, Danhauer SC, Tooze JA, Blackstock AW, Spangler J, Thomas L, et al. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. Oncologist. 2012;17(3):455–62.Google Scholar
  61. 61.
    Coups EJ, Coups E, Dhingra L, Heckman C, Manne S. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009;24(S2):480–6.Google Scholar
  62. 62.
    Sarna L. Tobacco interventions by oncology nurses in clinical practice. Cancer. 2000;89(4):881–9.Google Scholar
  63. 63.
    Fiore M. Treating tobacco use and dependence: 2008 guidelines. United States Tobacco Use and Dependence Guideline Panel; 2008.Google Scholar
  64. 64.
    Maguire CP, Ryan J, Kelly A, O’Neill D, Coakley D, Walsh JB. Do patient age and medical condition influence medical advice to stop smoking? Age Ageing. 2000;29(3):264–6.Google Scholar
  65. 65.
    Edwards SA, Bondy S, Callaghan R, Mann R. Prevalence of unassisted quit attempts in population-based studies: a systematic review of the literature. Addict Behav. 2014;39(3):512–9.Google Scholar
  66. 66.
    Malarcher A. Quitting smoking among adults—United States, 2001-2010. JAMA. 2011;306(23):2554.Google Scholar
  67. 67.
    Blair NA, Husten CG, Mariolis P, Pechacek TF, Starr G, Centers for Disease Control and Prevention (U.S.) et al. Best practices for comprehensive tobacco control programs. [Atlanta, GA]: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health; 2007.Google Scholar
  68. 68.
    National Cancer Institute. Cancer Center Cessation Initiative. 2018. https://cancercontrol.cancer.gov/brp/tcrb/cessation-initiative.html. Accessed 21 Oct 2018.
  69. 69.
    Patrick D. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93.Google Scholar
  70. 70.
    Comprehensive Cancer Control National Partnership. Increase availability of tobacco cessation services for cancer survivors. 2016. http://www.cccnationalpartners.org/increase-availability-tobacco-cessation-services-cancer-survivors. Accessed 3 Aug 2017.

Copyright information

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2019

Authors and Affiliations

  • M. Shayne Gallaway
    • 1
    Email author
  • Rebecca Glover-Kudon
    • 2
  • Behnoosh Momin
    • 1
  • Mary Puckett
    • 1
  • Natasha Buchanan Lunsford
    • 1
  • Kathleen R. Ragan
    • 1
  • Elizabeth A. Rohan
    • 1
  • Stephen Babb
    • 2
  1. 1.Centers for Disease Control and Prevention, Division of Cancer Prevention and ControlNational Center for Chronic Disease Prevention and Health PromotionAtlantaUSA
  2. 2.Centers for Disease Control and Prevention, Office on Smoking and HealthNational Center for Chronic Disease Prevention and Health PromotionAtlantaUSA

Personalised recommendations